Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis

Host-directed therapies (HDTs) are emerging as a potential valid support in the treatment of drug-resistant tuberculosis (TB). Following our recent report indicating that genetic and pharmacological inhibition of transglutaminase 2 (TG2) restricts Mycobacterium tuberculosis (Mtb) replication in macr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Palucci, Ivana, Maulucci, Giuseppe, De Maio, Flavio, Sali, Michela, Romagnoli, Alessandra, Petrone, Linda, Fimia, Gian Maria, Sanguinetti, Maurizio, Goletti, Delia, De Spirito, Marco, Piacentini, Mauro, Delogu, Giovanni
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6992558/
https://ncbi.nlm.nih.gov/pubmed/32038614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.03042
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars